Clinical Trial: Evaluate the Safety and Efficacy of CAR-T Cells in the Treatment of R/R Neuromyelitis Optica
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Neuromyelitis Optica
Study Type: INTERVENTIONAL
Official Title: A Study on the Safety and Efficacy of Chimeric Antigen Receptor T Cells in the Treatment of Recurrent/Refractory Neuromyelitis Optica
Brief Summary:
This is a single-arm, open-label, single-center, phase I study.The primary objective is to evaluate the safety of CD19 CAR-T therapy for patients with relapsed or refractory Neuromyelitis Optica, and to evaluate the pharmacokinetics of CD19 CAR-T in patients.
Read more